ro 48-8071 and liquiritigenin

ro 48-8071 has been researched along with liquiritigenin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Besch-Williford, C; Hyder, SM; Liang, Y	1

Other Studies

1 other study(ies) available for ro 48-8071 and liquiritigenin

Article	Year
The estrogen receptor beta agonist liquiritigenin enhances the inhibitory effects of the cholesterol biosynthesis inhibitor RO 48-8071 on hormone-dependent breast-cancer growth. Breast cancer research and treatment, 2022, Volume: 192, Issue:1 Topics: Animals; Benzophenones; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cholesterol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Female; Flavanones; Humans; Mice; Mice, Nude; Xenograft Model Antitumor Assays	2022

Article

Year

The estrogen receptor beta agonist liquiritigenin enhances the inhibitory effects of the cholesterol biosynthesis inhibitor RO 48-8071 on hormone-dependent breast-cancer growth.

Breast cancer research and treatment, 2022, Volume: 192, Issue:1

Topics: Animals; Benzophenones; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cholesterol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Female; Flavanones; Humans; Mice; Mice, Nude; Xenograft Model Antitumor Assays

2022